Loading...
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis
Glioblastoma is a rare and aggressive primary brain tumor with incidence of 5 per 100,000 annually. We report a 50-year-old woman diagnosed with glioblastoma within 3 years of induction of fingolimod therapy for relapsing-remitting multiple sclerosis. Fingolimod, an immunomodulating agent used in th...
Na minha lista:
| Udgivet i: | J Clin Neurosci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4925177/ https://ncbi.nlm.nih.gov/pubmed/26970935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jocn.2016.02.003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|